141 related articles for article (PubMed ID: 2713854)
41. Perfluorochemical emulsions can increase tumor radiosensitivity.
Teicher BA; Rose CM
Science; 1984 Mar; 223(4639):934-6. PubMed ID: 6695191
[TBL] [Abstract][Full Text] [Related]
42. Increased radiosensitivity of tumors by perfluorochemicals and carbogen.
Song CW; Zhang WL; Pence DM; Lee I; Levitt SH
Int J Radiat Oncol Biol Phys; 1985 Oct; 11(10):1833-6. PubMed ID: 3930442
[TBL] [Abstract][Full Text] [Related]
43. Tumor oxygenation and radiosensitization by pentoxifylline and a perflubron emulsion carbogen breathing.
Teicher B; Sotomayor E; Robinson M; Dupuis N; Schwartz G; Frei E
Int J Oncol; 1993 Jan; 2(1):13-21. PubMed ID: 21573510
[TBL] [Abstract][Full Text] [Related]
44. Radiosensitization of Hs-766T Pancreatic Tumor Xenografts in Mice Dosed with Dodecafluoropentane Nano-Emulsion-Preliminary Findings.
Johnson JL; Leos RA; Baker AF; Unger EC
J Biomed Nanotechnol; 2015 Feb; 11(2):274-81. PubMed ID: 26349303
[TBL] [Abstract][Full Text] [Related]
45. Influence of the 100% w/v perfluorooctyl bromide (PFOB) emulsion dose on tumour radiosensitivity.
Thomas C; Riess J; Guichard M
Int J Radiat Biol; 1991 Feb; 59(2):433-45. PubMed ID: 1671693
[TBL] [Abstract][Full Text] [Related]
46. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
Fingar VH; Mang TS; Henderson BW
Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983
[TBL] [Abstract][Full Text] [Related]
47. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
Rojas A; Vojnovic B; Johns H; Joiner MC; Martindale C; Fowler JF; Denekamp J
Radiother Oncol; 1996 Apr; 39(1):53-64. PubMed ID: 8735494
[TBL] [Abstract][Full Text] [Related]
48. Oxygenation of human tumor xenografts in nude mice by a perfluorochemical emulsion and carbogen breathing.
Teicher BA; Schwartz GN; Dupuis NP; Kusomoto T; Liu M; Liu F; Northey D
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1369-75. PubMed ID: 7849946
[TBL] [Abstract][Full Text] [Related]
49. A study of hypoxic cell radiosensitizer applied to Ehrlich ascite tumour: a comparison of FC43 emulsion and pentoxyfilline.
Wakasa T; Kawai N; Yanagi Y; Hayase Y; Kishi K
Br J Radiol; 2002 Nov; 75(899):909-12. PubMed ID: 12466257
[TBL] [Abstract][Full Text] [Related]
50. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
Teicher BA; Herman TS; Rose CM
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1187-92. PubMed ID: 3141321
[TBL] [Abstract][Full Text] [Related]
51. Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation.
Holden SA; Herman TS; Teicher BA
Radiother Oncol; 1990 May; 18(1):59-70. PubMed ID: 2113698
[TBL] [Abstract][Full Text] [Related]
52. Radiosensitivity, blood perfusion and tumour oxygenation after perflubron emulsion injection.
Vitu-Loas L; Thomas C; Chavaudra N; Guichard M
Radiother Oncol; 1993 May; 27(2):149-55. PubMed ID: 8356225
[TBL] [Abstract][Full Text] [Related]
53. Modulation of tumor oxygenation and radiosensitivity by a perfluorooctylbromide emulsion.
Rockwell S; Kelley M; Irvin CG; Hughes CS; Porter E; Yabuki H; Fischer JJ
Radiother Oncol; 1991 Oct; 22(2):92-8. PubMed ID: 1957007
[TBL] [Abstract][Full Text] [Related]
54. Perfluorochemical emulsions: oxygen breathing in radiation sensitization and chemotherapy modulation.
Teicher BA; Herman TS; Frei E
Important Adv Oncol; 1992; ():39-59. PubMed ID: 1582677
[No Abstract] [Full Text] [Related]
55. Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathing.
Teicher BA; Sotomayor EA; Dupuis NP; Kusumoto T; Menon K
J Cancer Res Clin Oncol; 1994; 120(10):593-8. PubMed ID: 7929530
[TBL] [Abstract][Full Text] [Related]
56. A comparison of the effects of tumour growth delay of fractionated and single dose irradiation when administered with misonidazole (Ro-07-0582).
Reddy EK
Br J Cancer Suppl; 1978 Jun; 3():250-4. PubMed ID: 277241
[TBL] [Abstract][Full Text] [Related]
57. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo.
Kim GE; Song CW
Cancer Chemother Pharmacol; 1989; 25(2):99-102. PubMed ID: 2513138
[TBL] [Abstract][Full Text] [Related]
58. Oxygenation effect of fluosol-DA on hypoxic tumor tissue and retention of PFCs in the tumor-bearing rats.
Watanabe M; Okamoto H; Ohyanaqi H; Saitoh Y; Yano K; Tsuda Y; Ueda Y; Yokoyama K
Biomater Artif Cells Artif Organs; 1988; 16(1-3):547-56. PubMed ID: 3140922
[TBL] [Abstract][Full Text] [Related]
59. Decreased tumor oxygenation after cyclophosphamide, reoxygenation and therapeutic enhancement with a perflubron emulsion carbogen breathing.
Teicher B; Dupuis N; Kusumoto T; Liu M; Liu F; Menon K; Schwartz G; Frei E
Int J Oncol; 1993 Aug; 3(2):197-203. PubMed ID: 21573348
[TBL] [Abstract][Full Text] [Related]
60. Tumor oxygenation after 1) carbogen and/or perflubron emulsion administration in tumor xenografts 2) carbogen administration in patients.
Guichard M; Lartigau E; Martin L; Thomas C; Weeger P; Lambin P; Le Ridant AM; Lusinchi A; Wibault P; Luboinski B
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1355-60. PubMed ID: 7849944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
